首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis
【24h】

Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis

机译:缺乏铁和HFE基因突变在巴西非酒精性脂肪性肝炎患者中的致病作用的证据

获取原文
           

摘要

The hypothesis of the role of iron overload associated with HFE gene mutations in the pathogenesis of nonalcoholic steatohepatitis (NASH) has been raised in recent years. In the present study, biochemical and histopathological evidence of iron overload and HFE mutations was investigated in NASH patients. Thirty-two NASH patients, 19 females (59%), average 49.2 years, 72% Caucasians, 12% Mulattoes and 12% Asians, were submitted to serum aminotransferase and iron profile determinations. Liver biopsies were analyzed for necroinflammatory activity, architectural damage and iron deposition. In 31 of the patients, C282Y and H63D mutations were tested by PCR-RFLP. Alanine aminotransferase levels were increased in 30 patients, 2.42 ± 1.12 times the upper normal limit on average. Serum iron concentration, transferrin saturation and ferritin averages were 99.4 ± 31.3 g/dl, 33.1 ± 12.7% and 219.8 ± 163.8 μg/dl, respectively, corresponding to normal values in 93.5, 68.7 and 78.1% of the patients. Hepatic siderosis was observed in three patients and was not associated with architectural damage (P = 0.53) or with necroinflammatory activity (P = 0.27). The allelic frequencies (N = 31) found were 1.6 and 14.1% for C282Y and H63D, respectively, which were compatible with those described for the local population. In conclusion, no evidence of an association of hepatic iron overload and HFE mutations with NASH was found. Brazilian NASH patients comprise a heterogeneous group with many associated conditions such as hyperinsulinism, environmental hepatotoxin exposure and drugs, but not hepatic iron overload, and their disease susceptibility could be related to genetic and environmental features other than HFE mutations.
机译:近年来,人们提出了与HFE基因突变相关的铁超负荷在非酒精性脂肪性肝炎(NASH)发病机理中的作用的假说。在本研究中,对NASH患者中铁超载和HFE突变的生化和组织病理学证据进行了调查。对32例NASH患者进行了血清氨基转移酶和铁谱分析,其中19例女性(59%),平均49.2岁,高加索人72%,混血儿12%,亚洲人12%。分析了肝活检的坏死性炎症活性,建筑破坏和铁沉积。在31名患者中,通过PCR-RFLP测试了C282Y和H63D突变。 30名患者的丙氨酸氨基转移酶水平升高,是平均正常上限的2.42±1.12倍。血清铁浓度,转铁蛋白饱和度和铁蛋白平均值分别为99.4±31.3 g / dl,33.1±12.7%和219.8±163.8μg/ dl,分别对应于93.5%,68.7和78.1%的患者正常值。在三名患者中观察到肝铁化病,与建筑结构损害(P = 0.53)或坏死性炎症活动(P = 0.27)无关。 C282Y和H63D的等位基因频率(N = 31)分别为1.6%和14.1%,与当地人群描述的等位基因频率兼容。总之,没有发现肝铁超负荷和HFE突变与NASH相关的证据。巴西NASH患者由异质性组组成,具有许多相关病症,例如高胰岛素血症,环境肝毒素暴露和药物,但肝铁超载则不然,他们的疾病易感性可能与HFE突变以外的遗传和环境特征有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号